Related references
Note: Only part of the references are listed.Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject
Stefano Bonora et al.
CLINICAL INFECTIOUS DISEASES (2007)
Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: Implications for predicting clinical drug interactions
Vaishali Dixit et al.
DRUG METABOLISM AND DISPOSITION (2007)
Interaction between lopinavir/ritonavir and warfarin
Christine A. Hughes et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir
B. Luethi et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Lopinavir/ritonavir reduces bupropion plasma concentrations in healthy subjects
G. W. Hogeland et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir
Manoli Vourvahis et al.
PHARMACOTHERAPY (2007)
Lopinavir/ritonavir reduces lamotrigine plasma concentrations in healthy subjects
Manon J. van der Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Potent cytochrome P4502C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir
Gerd Mikus et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Pharmacology of systemic antifungal agents
Elizabeth S. Dodds Ashley et al.
CLINICAL INFECTIOUS DISEASES (2006)
Time-dependent interaction between lopinavir/ritonavir and fexofenadine
Rolf P. G. van Heeswijk et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient
Maxime Touzot et al.
AIDS (2006)
Ritonavir has minimal impact on the pharmacokinetic disposition of a single dose of Bupropion administered to human volunteers
LM Hesse et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Possible interaction between lopinavir/ritonavir and valproic acid exacerbates bipolar disorder
NL Sheehan et al.
ANNALS OF PHARMACOTHERAPY (2006)
Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers
RE Aarnoutse et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation
DL Zhang et al.
DRUG METABOLISM AND DISPOSITION (2005)
Lack of an effect of atazanavir on steady-state pharmacokineties of methadone in patients chronically treated for opiate addiction
G Friedland et al.
AIDS (2005)
UDP-glucuronosyltransferases and clinical drug-drug interactions
TKL Kiang et al.
PHARMACOLOGY & THERAPEUTICS (2005)
Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers
CM Smith et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2005)
Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases, and glucuronyl transferases in human: An in vitro study
RS Obach et al.
DRUG METABOLISM AND DISPOSITION (2005)
Interactions between antiretrovirals and antineoplastic drug therapy
T Antoniou et al.
CLINICAL PHARMACOKINETICS (2005)
The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone
MJ Shelton et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Coadministration of Lopinavir/Ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction
ML Lim et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
R Ding et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Ritonavir decreases the nonrenal clearance of digoxin in healthy volunteers with known MDR1 genotypes
SR Penzak et al.
THERAPEUTIC DRUG MONITORING (2004)
Effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults
R DiCenzo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19
JG Gerber et al.
CHIRALITY (2004)
Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part II
SC Armstrong et al.
PSYCHOSOMATICS (2003)
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects
MA Boyd et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients
EF McCance-Katz et al.
CLINICAL INFECTIOUS DISEASES (2003)
Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir
RC Stevens et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Digoxin toxicity and ritonavir: a drug interaction mediated through p-glycoprotein?
EJ Phillips et al.
AIDS (2003)
Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein
D Vishnuvardhan et al.
AIDS (2003)
Apparent mechanism-based inhibition of human CYP3A in-vitro by lopinavir
JL Weemhoff et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality, part I
SC Armstrong et al.
PSYCHOSOMATICS (2003)
Glucuronidation enzymes, genes and psychiatry
J de Leon
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2003)
Drug interactions between antiretroviral drugs and comedicated agents
MMR de Maat et al.
CLINICAL PHARMACOKINETICS (2003)
Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers
SR Penzak et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers
Y Khaliq et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Cytochromes P450 and metabolism of xenobiotics
P Anzenbacher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Drug therapy: Interactions among drugs for HIV and opportunistic infections
SC Piscitelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Pharmacogenetics of warfarin elimination and its clinical implications
H Takahashi et al.
CLINICAL PHARMACOKINETICS (2001)
The effect of ritonavir on the pharmacokinetics of meperidine and normeperidine
SC Piscitelli et al.
PHARMACOTHERAPY (2000)
Alprazolam-ritonavir interaction: Implications for product labeling
DJ Greenblatt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors
MT Huisman et al.
AIDS (2000)
Decreased methadone effect after ritonavir initiation
SM Geletko et al.
PHARMACOTHERAPY (2000)
Share Paper
